Literature DB >> 25119165

Brain-derived neurotrophic factor and interleukin-6 levels in the serum and cerebrospinal fluid of children with viral infection-induced encephalopathy.

Shinichiro Morichi1, Gaku Yamanaka, Yu Ishida, Shingo Oana, Yasuyo Kashiwagi, Hisashi Kawashima.   

Abstract

We investigated changes in the brain-derived neurotrophic factor (BDNF) and interleukin (IL)-6 levels in pediatric patients with central nervous system (CNS) infections, particularly viral infection-induced encephalopathy. Over a 5-year study period, 24 children hospitalized with encephalopathy were grouped based on their acute encephalopathy type (the excitotoxicity, cytokine storm, and metabolic error types). Children without CNS infections served as controls. In serum and cerebrospinal fluid (CSF) samples, BDNF and IL-6 levels were increased in all encephalopathy groups, and significant increases were noted in the influenza-associated and cytokine storm encephalopathy groups. Children with sequelae showed higher BDNF and IL-6 levels than those without sequelae. In pediatric patients, changes in serum and CSF BDNF and IL-6 levels may serve as a prognostic index of CNS infections, particularly for the diagnosis of encephalopathy and differentiation of encephalopathy types.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119165     DOI: 10.1007/s11064-014-1409-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Neurotrophin-3 levels in cerebrospinal fluid from children with bacterial meningitis, viral meningitis, or encephalitis.

Authors:  Y Mizuno; H Takada; K Urakami; K Ihara; R Kira; A Suminoe; S Ohga; T Aoki; T Hara
Journal:  J Child Neurol       Date:  2000-01       Impact factor: 1.987

Review 2.  Neurotrophin-regulated signalling pathways.

Authors:  Louis F Reichardt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

3.  Differential mRNA expression of neurotrophic factors GDNF, BDNF, and NT-3 in experimental herpes simplex virus encephalitis.

Authors:  Johann Sellner; Thorsten Lenhard; Jürgen Haas; Regina von Einsiedel; Uta Meyding-Lamadé
Journal:  Brain Res Mol Brain Res       Date:  2005-04-22

Review 4.  Neuronal instability: implications for Rett's syndrome.

Authors:  E C Azmitia
Journal:  Brain Dev       Date:  2001-12       Impact factor: 1.961

5.  Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis.

Authors:  Chia-Chang Hsieh; Jen-Her Lu; Shu-Jen Chen; Cheng-Chou Lan; Wen-Chi Chow; Ren-Bin Tang
Journal:  Childs Nerv Syst       Date:  2008-09-25       Impact factor: 1.475

6.  Expression of neurotrophic factors in cerebrospinal fluid and plasma of children with viral and bacterial meningoencephalitis.

Authors:  A Chiaretti; A Antonelli; M Piastra; O Genovese; G Polidori; L Aloe
Journal:  Acta Paediatr       Date:  2004-09       Impact factor: 2.299

7.  Expressions of brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid and plasma of children with meningitis and encephalitis/encephalopathy.

Authors:  Shinichiro Morichi; Yasuyo Kashiwagi; Koji Takekuma; Akinori Hoshika; Hisashi Kawashima
Journal:  Int J Neurosci       Date:  2013-01       Impact factor: 2.292

Review 8.  Critical role of brain-derived neurotrophic factor in mood disorders.

Authors:  Kenji Hashimoto; Eiji Shimizu; Masaomi Iyo
Journal:  Brain Res Brain Res Rev       Date:  2004-05

9.  Neurotrophin-4 and glial cell line-derived neurotrophic factor in cerebrospinal fluid from meningitis/encephalitis patients.

Authors:  Yoichi Tokunaga; Ryutaro Kira; Yasushi Takahata; Kenjiro Gondo; Yumi Mizuno; Tomonobu Aoki; Toshiro Hara
Journal:  Pediatr Neurol       Date:  2002-08       Impact factor: 3.372

10.  Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy.

Authors:  George Stoica; Gina Lungu; Hun-Taek Kim; Paul K Y Wong
Journal:  Brain Res       Date:  2008-03-08       Impact factor: 3.252

View more
  7 in total

Review 1.  Exercise as a Positive Modulator of Brain Function.

Authors:  Karim A Alkadhi
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

2.  Pathological analysis of children with childhood central nervous system infection based on changes in chemokines and interleukin-17 family cytokines in cerebrospinal fluid.

Authors:  Shinichiro Morichi; Tomomi Urabe; Natsumi Morishita; Mika Takeshita; Yu Ishida; Shingo Oana; Gaku Yamanaka; Yasuyo Kashiwagi; Hisashi Kawashima
Journal:  J Clin Lab Anal       Date:  2017-03-17       Impact factor: 2.352

Review 3.  Effect of Exercise on Major Depressive Disorder and Schizophrenia: A BDNF Focused Approach.

Authors:  Evrim Gökçe; Emel Güneş; Erhan Nalçaci
Journal:  Noro Psikiyatr Ars       Date:  2019-10-15       Impact factor: 1.339

4.  Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration.

Authors:  David Azoulay; Mona Shehadeh; Svetlana Chepa; Ety Shaoul; Masad Baroum; Netanel A Horowitz; Eduard Kaykov
Journal:  J Infect       Date:  2020-06-20       Impact factor: 6.072

5.  Influence of Previous COVID-19 and Mastitis Infections on the Secretion of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in Human Milk.

Authors:  Veronique Demers-Mathieu; Dustin J Hines; Rochelle M Hines; Sirima Lavangnananda; Shawn Fels; Elena Medo
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

6.  Altered Cytokine and BDNF Levels in Individuals with Autism Spectrum Disorders.

Authors:  Yvonne M Y Han; Suk-Yu Yau; Melody M Y Chan; Chun-Kwok Wong; Agnes S Chan
Journal:  Brain Sci       Date:  2022-03-29

7.  Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.

Authors:  Sonu Bhaskar; Akansha Sinha; Maciej Banach; Shikha Mittoo; Robert Weissert; Joseph S Kass; Santhosh Rajagopal; Anupama R Pai; Shelby Kutty
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.